BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1720152)

  • 1. Detection of mutations associated with zidovudine resistance in human immunodeficiency virus by use of the polymerase chain reaction.
    Richman DD; Guatelli JC; Grimes J; Tsiatis A; Gingeras T
    J Infect Dis; 1991 Dec; 164(6):1075-81. PubMed ID: 1720152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects.
    Boucher CA; O'Sullivan E; Mulder JW; Ramautarsing C; Kellam P; Darby G; Lange JM; Goudsmit J; Larder BA
    J Infect Dis; 1992 Jan; 165(1):105-10. PubMed ID: 1370174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel mutation in the human immunodeficiency virus type 1 reverse transcriptase gene that encodes cross-resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine.
    Gu Z; Gao Q; Li X; Parniak MA; Wainberg MA
    J Virol; 1992 Dec; 66(12):7128-35. PubMed ID: 1279198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of self-sustained sequence replication amplification reaction to analyze and detect mutations in zidovudine-resistant human immunodeficiency virus.
    Gingeras TR; Prodanovich P; Latimer T; Guatelli JC; Richman DD; Barringer KJ
    J Infect Dis; 1991 Dec; 164(6):1066-74. PubMed ID: 1955709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zidovudine-resistant human immunodeficiency virus type 1 genomes detected in plasma distinct from viral genomes in peripheral blood mononuclear cells.
    Smith MS; Koerber KL; Pagano JS
    J Infect Dis; 1993 Feb; 167(2):445-8. PubMed ID: 7678429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 syncytium-inducing phenotype, virus burden, codon 215 reverse transcriptase mutation and CD4 cell decline in zidovudine-treated patients.
    Kozal MJ; Shafer RW; Winters MA; Katzenstein DA; Aguiniga E; Halpern J; Merigan TC
    J Acquir Immune Defic Syndr (1988); 1994 Aug; 7(8):832-8. PubMed ID: 7517448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy.
    Chow YK; Hirsch MS; Merrill DP; Bechtel LJ; Eron JJ; Kaplan JC; D'Aquila RT
    Nature; 1993 Feb; 361(6413):650-4. PubMed ID: 7679778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of selective polymerase chain reaction primers and differential probe hybridization of polymerase chain reaction products for determination of relative amounts of codon 215 mutant and wild-type HIV-1 populations.
    Eastman PS; Urdea M; Besemer D; Stempien M; Kolberg J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):264-73. PubMed ID: 7540490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term persistence of zidovudine resistance mutations in plasma isolates of human immunodeficiency virus type 1 of dideoxyinosine-treated patients removed from zidovudine therapy.
    Smith MS; Koerber KL; Pagano JS
    J Infect Dis; 1994 Jan; 169(1):184-8. PubMed ID: 7506280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotypic evolution of HIV-1 isolates from patients after a switch of therapy from zidovudine to didanosine.
    Masquelier B; Pellegrin I; Ruffault A; Ragnaud JM; Morlat P; Michelet C; Doignon F; Biteau N; Fleury HJ
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(4):330-4. PubMed ID: 7533640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reverse transcriptase sequence of paired isolates of cerebrospinal fluid and blood from patients infected with human immunodeficiency virus type 1 during zidovudine treatment.
    Di Stefano M; Sabri F; Leitner T; Svennerholm B; Hagberg L; Norkrans G; Chiodi F
    J Clin Microbiol; 1995 Feb; 33(2):352-5. PubMed ID: 7536214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural occurrence of drug resistance mutations in the reverse transcriptase of human immunodeficiency virus type 1 isolates.
    Nájera I; Richman DD; Olivares I; Rojas JM; Peinado MA; Perucho M; Nájera R; López-Galíndez C
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1479-88. PubMed ID: 7534096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations.
    Shafer RW; Kozal MJ; Winters MA; Iversen AK; Katzenstein DA; Ragni MV; Meyer WA; Gupta P; Rasheed S; Coombs R
    J Infect Dis; 1994 Apr; 169(4):722-9. PubMed ID: 8133086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of HIV isolates arising after prolonged zidovudine therapy.
    Mayers DL; McCutchan FE; Sanders-Buell EE; Merritt LI; Dilworth S; Fowler AK; Marks CA; Ruiz NM; Richman DD; Roberts CR
    J Acquir Immune Defic Syndr (1988); 1992; 5(8):749-59. PubMed ID: 1381438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pol mutations conferring zidovudine and didanosine resistance with different effects in vitro yield multiply resistant human immunodeficiency virus type 1 isolates in vivo.
    Eron JJ; Chow YK; Caliendo AM; Videler J; Devore KM; Cooley TP; Liebman HA; Kaplan JC; Hirsch MS; D'Aquila RT
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1480-7. PubMed ID: 7689822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug resistance and heterogeneous long-term virologic responses of human immunodeficiency virus type 1-infected subjects to zidovudine and didanosine combination therapy. The AIDS Clinical Trials Group 143 Virology Team.
    Shafer RW; Iversen AK; Winters MA; Aguiniga E; Katzenstein DA; Merigan TC
    J Infect Dis; 1995 Jul; 172(1):70-8. PubMed ID: 7541064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reverse transcriptase mutations in sequential HIV-1 isolates in a patient with AIDS.
    Gurusinghe AD; Land SA; Birch C; McGavin C; Hooker DJ; Tachedjian G; Doherty R; Deacon NJ
    J Med Virol; 1995 Jul; 46(3):238-43. PubMed ID: 7561796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence analysis of reverse transcriptase genes of zidovudine (AZT)-resistant and -sensitive human immunodeficiency virus type 1 strains.
    Sheehy N; Desselberger U
    J Gen Virol; 1993 Feb; 74 ( Pt 2)():223-8. PubMed ID: 7679140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of azidothymidine-resistant human immunodeficiency virus type 1 RNA genotypes in posttreatment sera.
    Albert J; Wahlberg J; Lundeberg J; Cox S; Sandström E; Wahren B; Uhlén M
    J Virol; 1992 Sep; 66(9):5627-30. PubMed ID: 1380098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonisotopic hybridization assay for determination of relative amounts of genotypic human immunodeficiency virus type 1 zidovudine resistance.
    Eastman PS; Boyer E; Mole L; Kolberg J; Urdea M; Holodniy M
    J Clin Microbiol; 1995 Oct; 33(10):2777-80. PubMed ID: 8567926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.